Skip to content

Clinical Study of Prediction of Glucocorticoid Efficacy by cytokins in Patients with Primary Nephrotic Syndrome

Clinical Study of Prediction of Glucocorticoid Efficacy by cytokins in Patients with Primary Nephrotic Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002809
Enrollment
Unknown
Registered
2012-05-24
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic nephrotic syndrome

Interventions

1:Given methylprednisolone according to the status of the patients

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) >=18years old; (2) Primary nephrotic syndrome and no application of glucocorticoid or immunosuppressive agents; (3) Blood pressure can effectively control less than 130/80mmHg or without hypertension; (4) Taking an ARB or ACEI drugs more than four weeks; (5) Serum creatinine level <=200umol/L; (6) Routine renal biopsy.

Exclusion criteria

Exclusion criteria: (1) All kinds of secondary nephrotic syndrome, such as lupus nephritis, Henoch-Schonlein purpura nephritis, diabetic nephropathy, hypertensive nephropathy and so on; (2) BMI between =25; (3) Urine protein quantitative maitains 0.3-3g/24h after prescription with glucocorticoid 8 weeks; (4) The patients participating the other trials; (5) Researchers consider the patients not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Cytokines Level;

Secondary

MeasureTime frame
Cumulative remission;Serum creatinine;eGFR;Serum albumin;24h Urine protein quantity;

Countries

China

Contacts

Public ContactXie Hua
wlciq007@163.com+86 15541191277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026